USPTO serial 98143029
BIOCOLONIZE
Reviewed by CopyMark Law Group
Status 651
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAW, CHRISTOPHER M
- Law office
- TMEG LAW OFFICE 103
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOCOLONIZE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brent Capehart
Brent Capehart PALMER IP INC.704-1478 WEST HASTINGS STREETVANCOUVER, BC, V6G3J6CANADAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders | ACTIVE | — |
| 042 | Medical, scientific and veterinary research, namely clinical trials; conducting interventional clinical studies; pharmaceutical drug development services for others; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the fields of pharmaceuticals; medical, scientific and veterinary research in the fields of clinical trials and post-market trials; research on the subject of pharmaceuticals; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 20, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 14, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 16, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 14, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 10, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 24, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 24, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 24, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2023 | NWAP | NEW APPLICATION ENTERED | — |